2018
DOI: 10.1002/asia.201801136
|View full text |Cite
|
Sign up to set email alerts
|

Small Molecules to Target the Selenoprotein Thioredoxin Reductase

Abstract: The selenoprotein thioredoxin reductase (TrxR) enzymes are the only identified proteins that maintain thioredoxin (Trx) proteins in a reduced state under physiological conditions, and consequently play a pivotal role in the regulation of various cellular redox signaling pathways involved in cell differentiation, growth, and death. The elevated expression of TrxR enzymes has been observed in different types of cancer cells, and this overexpression is of pathological significance in maintaining tumor phenotypes,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
24
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(27 citation statements)
references
References 82 publications
1
24
1
Order By: Relevance
“…[23][24][25] TrxR is a selenocystein enzyme, one of only a few dozen encoded in the human genome [26] and the selective targeting of the selenocysteine residue by electrophilic compounds (specifically, Michael acceptors) -in the presence of much more abundant nucleophilic cysteines -has been regarded as the key to achieving therapeutic success. [27] With 23 novel Δ α,β -spirobutenolides at hand (4 a-o and 7 ah), we became curious if this new chemotype would be, on the one hand, capable of inhibiting TrxR and, on the other hand would display potential for selective targeting of selenocysteine in the chemically reconstituted excess-cysteine environment.…”
Section: Resultsmentioning
confidence: 99%
“…[23][24][25] TrxR is a selenocystein enzyme, one of only a few dozen encoded in the human genome [26] and the selective targeting of the selenocysteine residue by electrophilic compounds (specifically, Michael acceptors) -in the presence of much more abundant nucleophilic cysteines -has been regarded as the key to achieving therapeutic success. [27] With 23 novel Δ α,β -spirobutenolides at hand (4 a-o and 7 ah), we became curious if this new chemotype would be, on the one hand, capable of inhibiting TrxR and, on the other hand would display potential for selective targeting of selenocysteine in the chemically reconstituted excess-cysteine environment.…”
Section: Resultsmentioning
confidence: 99%
“…RSS- and RSeS-specific fluorescent probes have long been used for protein labeling [37] , [66] , [67] , [68] . For the purpose of drug simulation and structural screening, researchers have synthesized various RSS-specific fluorescent probes [69] .…”
Section: Introductionmentioning
confidence: 99%
“…At the beginning of the 21st century, researchers synthesized various types of highly selective RSeS-specific fluorescent probes capable of operating under physiological conditions by simulating the structure of RSS probes and optimizing the detection environment. Fluorescent probes based on S N Ar reaction for RSS and RSeS have been hot spots in this field [7] , [8] , [66] .…”
Section: Introductionmentioning
confidence: 99%
“…30,31 In contrast however, 1,2-dithiolanes have also been reported as reduction-sensing units with a remarkable selectivity for TrxR. The fluorogenic TRFS probes 14,16,32,33 and prodrugs 15 have been commercialised and extensively reviewed [34][35][36][37][38] (Fig 1e; overview in Fig S1b). These probes have since been used to study the role of TrxR in Parkinson's disease 39 and stroke 33 , and have been employed for mechanistic validation of putative TrxR inhibitors during screening approaches.…”
Section: Introductionmentioning
confidence: 99%